Please login to the form below
AMICULUM boosts global healthcare communications offering with a new specialist agency, Seques®
AMICULUM is entering its 18th year of growth as an independent healthcare communications and consulting business. Today we are delighted to announce the launch of the first communications agency specializing in genetically informed healthcare.
Advances in the
understanding of the genetic basis of disease are leading to major developments
in the diagnosis and treatment of a wide range of both rare and common
disorders.
Bringing with them extensive healthcare communications experience, Jenny Szkolar and Patricia Jones have joined AMICULUM to lead Seques, combining expertise in genomics with a global agency platform.
“We’re really excited to take Seques into its first year. We’re fortunate to be able to collaborate with experts at the forefront of genomics to enhance knowledge of life-changing medicines among healthcare professionals and patients”.
Richard Allcorn, co-founder of AMICULUM added “this is a very exciting development for AMICULUM and Seques and reinforces our commitment to diversifying our offerings to meet the changing needs of our clients and the industry.”
The Seques brand name and symbol are inspired by DNA sequencing with microarray technology.
About AMICULUM
AMICULUM (www.amiculum.biz) is an independent global healthcare communications, consulting and learning business with a global team of over 220 healthcare communications professionals, based in New Zealand, China, Singapore, UAE, Switzerland, UK and the USA. It partners with leading pharmaceutical, biotechnology and medical device companies in some of the most complex and exciting areas of medicine. AMICULUM comprises a cluster of 8 specialized agencies: 7.4®, Comradis®, Delta Kn, Evida, Mudskipper®, Seques®, AMICULUM Digital and AMICULUM Design.
Contact details
Jenny Szkolar: jenny.szkolar@seques.biz
Patricia Jones: patricia.jones@seques.biz
Bringing with them extensive healthcare communications experience, Jenny Szkolar and Patricia Jones have joined AMICULUM to lead Seques, combining expertise in genomics with a global agency platform.
“We’re really excited to take Seques into its first year. We’re fortunate to be able to collaborate with experts at the forefront of genomics to enhance knowledge of life-changing medicines among healthcare professionals and patients”.
Richard Allcorn, co-founder of AMICULUM added “this is a very exciting development for AMICULUM and Seques and reinforces our commitment to diversifying our offerings to meet the changing needs of our clients and the industry.”
The Seques brand name and symbol are inspired by DNA sequencing with microarray technology.
About AMICULUM
AMICULUM (www.amiculum.biz) is an independent global healthcare communications, consulting and learning business with a global team of over 220 healthcare communications professionals, based in New Zealand, China, Singapore, UAE, Switzerland, UK and the USA. It partners with leading pharmaceutical, biotechnology and medical device companies in some of the most complex and exciting areas of medicine. AMICULUM comprises a cluster of 8 specialized agencies: 7.4®, Comradis®, Delta Kn, Evida, Mudskipper®, Seques®, AMICULUM Digital and AMICULUM Design.
Contact details
Jenny Szkolar: jenny.szkolar@seques.biz
Patricia Jones: patricia.jones@seques.biz
Latest content on this profile
- AMICULUM® opens new UK offices and a flexible working hub to support its hybrid working approach
- The independent global healthcare communications agency, AMICULUM, has recently established new office locations in Glasgow and Manchester, as well as a flexible working hub in Sheffield
AMICULUM
- AMICULUM® collaborates with the University of Dundee to develop a new Master’s course in Science and Health Communication
AMICULUM
- Create, captivate and communicate: Cogent, a new full-service healthcare communications agency joins the AMICULUM® family
- With a team that prides itself on being scientists, strategists, artists and storytellers, Cogent aims to captivate audiences by taking the time to understand their needs and behaviours to stimulate engagement. They are committed to exploring novel approaches to connect with clinicians, patients, and internal stakeholders.
AMICULUM
- Life at AMICULUM
AMICULUM
- Rethinking our approach to rare disease communications during COVID-19 and beyond
- By Jonathan Morton
AMICULUM
- Strategic launch planning: familiar framework, new mindset
- By James Aird
AMICULUM
